A newly released observational analysis found that 84.4% of cancer patients treated off-label with a compounded combination of Ivermectin and Mebendazole experienced a clinical benefit.
The post Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients appeared first on Breitbart.
Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients
News
•
September 16, 2026
•
Source: Breitbart | https://feeds.feedburner.com/breitbart - Read Original
"Commision Art Work or Just pure Beauty."
"House Plans for Structures New and Old"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Adventure is where you chose to go."